ClinVar Miner

Submissions for variant NM_181523.3(PIK3R1):c.334+14A>C

gnomAD frequency: 0.31124  dbSNP: rs706714
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000147277 SCV000194649 likely benign not specified 2013-10-31 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000147277 SCV000540035 benign not specified 2016-03-29 criteria provided, single submitter clinical testing Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001812118 SCV001159487 benign not provided 2023-11-29 criteria provided, single submitter clinical testing
Invitae RCV001511909 SCV001719231 benign SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 2024-02-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001788049 SCV002029896 benign Agammaglobulinemia 7, autosomal recessive 2021-09-05 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001788051 SCV002029897 benign Immunodeficiency 36 2021-09-05 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001788050 SCV002029898 benign SHORT syndrome 2021-09-05 criteria provided, single submitter clinical testing
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan RCV000147277 SCV004102084 benign not specified 2023-11-12 criteria provided, single submitter clinical testing This variant is classified as Benign based on local population frequency. This variant was detected in 54% of patients studied by a panel of primary immunodeficiencies. Number of patients: 52. Only high quality variants are reported.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.